A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Weight gain is common in women going through menopause. It can be caused by a variety of factors, including hormone ...

In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., also had been resolved. Zepbound is approved to treat obesity and Mounjaro ...

It also suppresses appetite and boosts feelings of fullness, which can then lead to reduced food intake and potential weight loss ... time. There are potential long-term side effects of semaglutide.

The increase in weight loss ... week time point in its pivotal trial. Martin Holst Lange, Novo Nordisk's head of development, said that the safety and tolerability of the two doses of semaglutide ...

Bev battled health issues, including sleep apnoea and depression, and believed she was half-a-stone away from being ...

HIMS is enhancing offerings and expanding its health and wellness products and services to solidify its footing. However, macro challenges are likely to hurt its performance.

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

Four years after starting semaglutide, patients maintained an average weight loss of 10% of their body weight, a peer-reviewed 2024 study funded by Novo Nordisk found. Doctors say the drug’s ...

Don't miss out on the headlines from Weight Loss. Followed categories will be ... the results of a major clinical trial that showed semaglutide 2.4 mg (sold as Wegovy) reduced cardiovascular ...